Suppr超能文献

危重症 COVID-19 患者的发热管理:一项回顾性分析。

Fever management in critically ill COVID-19 patients: a retrospective analysis.

机构信息

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium -

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.

出版信息

Minerva Anestesiol. 2021 Nov;87(11):1217-1225. doi: 10.23736/S0375-9393.21.15711-6. Epub 2021 Aug 2.

Abstract

BACKGROUND

Fever has been reported as a common symptom in COVID-19 patients. The aim of the study was to describe the characteristics of COVID-19 critically ill patients with fever and to assess if fever management had an impact on some physiologic variables.

METHODS

This is a retrospective monocentric cohort analysis of critically ill COVID-19 patients admitted to the Department of Intensive Care Unit (ICU) of Erasme Hospital, Brussels, Belgium, between March 2020 and May 2020. Fever was defined as body temperature ≥38 °C during the ICU stay. We assessed the independent predictors of fever during ICU stay. We reported the clinical and physiological variables before and after the first treated episode of fever during the ICU stay.

RESULTS

A total of 72 critically ill COVID-19 patients were admitted to the ICU over the study period and were all eligible for the final analysis; 53 (74%) of them developed fever, after a median of 4 [0-13] hours since ICU admission. In the multivariable analysis, male gender (OR 5.41 [C.I. 95% 1.34-21.92]; P=0.02) and low PaO2/FiO2 ratio (OR 0.99 [C.I. 95% 0.99-1.00]; P=0.04) were independently associated with fever. After the treatment of the first febrile episode, heart rate and respiratory rate significantly decreased together with an increase in PaO2 and SaO2.

CONCLUSIONS

In our study, male gender and severe impairment of oxygenation were independently associated with fever in critically ill COVID-19 patients. Fever treatment reduced heart rate and respiratory rate and improved systemic oxygenation.

摘要

背景

发热是 COVID-19 患者的常见症状。本研究旨在描述 COVID-19 危重症患者发热的特征,并评估发热管理是否对某些生理变量有影响。

方法

这是一项回顾性单中心队列分析,纳入了 2020 年 3 月至 5 月期间比利时布鲁塞尔 Erasme 医院重症监护病房(ICU)收治的危重症 COVID-19 患者。发热定义为 ICU 住院期间体温≥38°C。我们评估了 ICU 住院期间发热的独立预测因素。报告了 ICU 住院期间首次治疗发热前后的临床和生理变量。

结果

研究期间共有 72 例危重症 COVID-19 患者入住 ICU,均符合最终分析标准;其中 53 例(74%)在入住 ICU 后 4 [0-13] 小时内出现发热。多变量分析显示,男性(OR 5.41 [95%CI 1.34-21.92];P=0.02)和低 PaO2/FiO2 比值(OR 0.99 [95%CI 0.99-1.00];P=0.04)与发热独立相关。首次发热治疗后,心率和呼吸频率显著下降,同时 PaO2和 SaO2 增加。

结论

在本研究中,男性和严重的氧合功能障碍与危重症 COVID-19 患者发热独立相关。发热治疗降低了心率和呼吸频率,改善了全身氧合。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验